US$ 26.58
Shopping security
ghk-cu peptide uses benefits side effects New cardiovascular clinical trials
New cardiovascular clinical trials in 2026
AOD9604 is not a licensed medicine or drug and has not been approved by the MHRA or FDA for any therapeutic use
Concentration and Focus
Size by weight:2 Gallon
Sorafenib [a small-molecule multi-kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFRs) rapidly accelerated fibrosarcoma (RAF) and other protein kinases] has been regarded as the standard of treatment for patients with advanced HCC since 2007 (Marisi et al., 2018)
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
US$40
Get nowSign up to your membership to get coupons up to
15%
Get nowOpportunity to enjoy order discount up to 15% off
Do not assume the request creates one new order automatically. Do not cancel an original order unless the agreed process requires it.
Avoid treating an earlier converted estimate as the final payable amount. Do not infer the seller's location from the currency alone.
Save the actual order reference regardless of the checkout method. Ask about any important difference that the checkout explanation leaves unresolved.
US$ 26.58
US$ 20.82
US$ 21.84
US$ 26.67
US$ 21.70